BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 34674464)

  • 21. Prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: a propensity score matching study.
    Zhou S; Jiang Y; Pei W; Liang J; Zhou Z
    BMC Cancer; 2022 Feb; 22(1):136. PubMed ID: 35109810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of laparoscopic lateral lymph node dissection for rectal cancer with and without routine resection of the visceral branches of internal iliac artery.
    Xiao J; Zhang X; Gu C; Yang X; Meng W; Wei M; Wang Z
    J Surg Oncol; 2024 Feb; 129(2):308-316. PubMed ID: 37849371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Robotic versus laparoscopic approach for minimally invasive lateral pelvic lymph node dissection of advanced lower rectal cancer: a retrospective study comparing short-term outcomes.
    Ishizaki T; Mazaki J; Kasahara K; Udo R; Tago T; Nagakawa Y
    Tech Coloproctol; 2023 Jul; 27(7):579-587. PubMed ID: 37157049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Outcomes of Total Mesorectal Excision and Lateral Lymph Node Dissection following Neoadjuvant Chemotherapy for Lower Rectal Cancer with Lateral Lymph Node Metastasis].
    Morohashi H; Uchida C; Ogasawara H; Hara Y; Akaishi T; Yachi T; Wakasa Y; Mitsuhashi Y; Tsuruta S; Sato K; Yoshida T; Umetsu S; Hasebe T; Suto A; Hakamada K
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1803-1805. PubMed ID: 30692359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of synchronous lateral pelvic nodal metastasis in rectal cancer in the era of neoadjuvant chemoradiation: A systemic review.
    Wong JSM; Tan GHC; Chia CS; Ong CJ; Teo MCC
    World J Gastrointest Surg; 2020 May; 12(5):247-258. PubMed ID: 32551030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
    Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
    JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in rectal cancer.
    Kroon HM; Hoogervorst LA; Hanna-Rivero N; Traeger L; Dudi-Venkata NN; Bedrikovetski S; Kusters M; Chang GJ; Thomas ML; Sammour T
    Eur J Surg Oncol; 2022 Jul; 48(7):1475-1482. PubMed ID: 35568607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lateral lymph node dissection reduces local recurrence of locally advanced lower rectal cancer in the absence of preoperative neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
    Gao X; Wang C; Yu Y; Singh D; Yang L; Zhou Z
    World J Surg Oncol; 2020 Nov; 18(1):304. PubMed ID: 33228677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Metastatic Lateral Lymph Nodes in Asian Patients with Lateral Lymph Node Dissection for Rectal Cancer: A Meta-analysis.
    Christou N; Meyer J; Combescure C; Balaphas A; Robert-Yap J; Buchs NC; Ris F
    World J Surg; 2021 May; 45(5):1537-1547. PubMed ID: 33543333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the short-term surgical outcomes of lateral lymph node dissection for low rectal cancer using a robotic-assisted transabdominal approach alone or supported by a transanal approach.
    Tokunaga T; Kashihara H; Yoshikawa K; Nakao T; Nishi M; Takasu C; Wada Y; Yoshimoto T; Shimada M
    Surg Endosc; 2024 Apr; 38(4):2070-2077. PubMed ID: 38438675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer.
    Matsuda T; Sumi Y; Yamashita K; Hasegawa H; Yamamoto M; Matsuda Y; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
    Int J Colorectal Dis; 2018 Apr; 33(4):367-374. PubMed ID: 29442155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term outcomes of laparoscopic lateral pelvic node dissection for advanced lower rectal cancer.
    Tokuhara K; Hishikawa H; Yoshida T; Ueyama Y; Yoshioka K; Sekimoto M
    Surg Endosc; 2021 Apr; 35(4):1572-1578. PubMed ID: 32246236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total mesorectal excision with and without lateral lymph node dissection: a systematic review of the literature.
    Longchamp G; Meyer J; Christou N; Popeskou S; Roos E; Toso C; Buchs NC; Ris F
    Int J Colorectal Dis; 2020 Jul; 35(7):1183-1192. PubMed ID: 32458399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laparoscopic lateral pelvic lymph node dissection for lower rectal cancer treated with preoperative chemoradiotherapy.
    Matsuda T; Hasegawa H; Yamashita K; Tanaka T; Yamamoto M; Kanaji S; Oshikiri T; Nakamura T; Sumi Y; Suzuki S; Kakeji Y
    Surg Endosc; 2020 Mar; 34(3):1425-1431. PubMed ID: 31628619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes.
    Schaap DP; Boogerd LSF; Konishi T; Cunningham C; Ogura A; Garcia-Aguilar J; Beets GL; Suzuki C; Toda S; Lee IK; Sammour T; Uehara K; Lee P; Tuynman JB; van de Velde CJH; Rutten HJT; Kusters M;
    Br J Surg; 2021 Mar; 108(2):205-213. PubMed ID: 33711144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic lateral pelvic lymph node dissection combined with removal of the internal iliac vessels in rectal cancer: how to standardize this surgical procedure.
    Beppu N; Jihyung S; Takenaka Y; Kimura K; Babaya A; Yasuhara M; Kataoka K; Uchino M; Ikeuchi H; Ikeda M
    Tech Coloproctol; 2021 May; 25(5):579-587. PubMed ID: 33650084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence vessel and ureter navigation during laparoscopic lateral lymph node dissection.
    Ryu S; Hara K; Kitagawa T; Okamoto A; Marukuchi R; Ito R; Nakabayashi Y
    Langenbecks Arch Surg; 2022 Feb; 407(1):305-312. PubMed ID: 34378079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Open versus laparoscopic lateral lymph node dissection for mid- and low- rectal cancer: a propensity score matching study.
    Zhang Y; Yang X; Wang D; Zhuang Z; Wei M; Meng W; Deng X; Wang Z
    ANZ J Surg; 2021 Nov; 91(11):2487-2492. PubMed ID: 34664380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-team lateral lymph node dissection assisted by the transanal approach for locally advanced lower rectal cancer: comparison with the conventional transabdominal approach.
    Narihiro S; Kitaguchi D; Ikeda K; Hasegawa H; Teramura K; Tsukada Y; Nishizawa Y; Ito M
    Surg Endosc; 2023 Jul; 37(7):5256-5264. PubMed ID: 36973567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transanally assisted lateral pelvic lymph node dissection for rectal cancer.
    Matsuda T; Sawada R; Hasegawa H; Yamashita K; Utsumi M; Harada H; Urakawa N; Goto H; Kanaji S; Oshikiri T; Kakeji Y
    Surg Endosc; 2023 Feb; 37(2):1562-1568. PubMed ID: 36123543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.